Home » Stocks » PANA » Company

Panacea Acquisition Corp. II (PANA)

Panacea Acquisition II currently trades with the ticker symbol PANA
Stock Price: $10.00 USD -0.02 (-0.20%)
Updated Apr 9, 2021 4:00 PM EDT - Market closed
Panacea Acquisition Corp. II
Country United States
Founded 2021
IPO Date Apr 7, 2021
Industry Blank Checks / SPAC
CEO Oleg Nodelman

Contact Details

Address:357 Tehama Street, Floor 3
San Francisco, CA 94103
United States
Phone (415) 966-0807

Stock Information

Ticker Symbol PANA
Exchange NASDAQ
Reporting Currency US Dollars
IPO Price $10.00
CIK Code 1828989
Employer ID 98-1578154

Company Description

Panacea Acquisition II is a newly incorporated blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

While we may pursue an initial business combination opportunity in any industry or geographical location, we intend to capitalize on our management team’s background and experience to identify innovative companies in the biotechnology sector that are domiciled in North America or Europe.

Our sponsor is an affiliate of EcoR1, an investment firm with over $2.7 billion in regulatory assets under management as of December 31, 2020. EcoR1 was established in March 2013 by our Chief Executive Officer, Oleg Nodelman, and is focused on therapeutic companies within the biotechnology sector.

Key Executives

NamePosition
Oleg NodelmanChief Executive Officer and Chairman Nominee
Scott PerlenChief Financial Officer
Scott PlatshonChief Operating Officer
Caroline StoutChief Investment Officer
Sarah MarriottSecretary and Director